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Though persistent or recurrent hypoglycemia in infancy is 
a very rare condition, it can cause major neurological damage 
and lifelong handicaps. Prompt recognition, specific diagnosis, 
and aggressive treatment are therefore essential to prevent the 
progression of neurological damage. The most common cause 
of this condition is persistent hyperinsulinemic hypoglycemia 
of infancy (PHHI), a syndrome previously known by a variety 
of different descriptive names, including nesidioblastosis and 
PHHI [1].
This report focuses on perioperative management of infants 
with PHHI. Because even healthy infants are vulnerable 
to difficulties with glycemic control during perioperative 
periods, proper anesthetic management of patients with 
hyperinsulinemic hypoglycemia is particularly critical. In this 
report, the authors demonstrate and discuss perioperative 
anesthetic management of glycemic control in a 7-month-old 
infant with PHHI who underwent near-total pancreatectomy.
The patient was a 6 M 27 D old male with a history of con-
vulsions beginning 3 months after his birth. Physical exam 
was normal, but the glucose levels (36-234 mg/dl) were 
uncontrollable in spite of sugar replacement treatment and 
feedings. Despite the hypoglycemia, the insulin level was 
normal (3.04 μIU/ml), but the insulin/glucose ratio was 7.6 
(Normal range: < 0.4). The patient was started on diazoxide 
treatment, which was continued for 6 days but was ineffective.
Other lab values, as well as studies including electroen-
cephalogram (EEG), brain radiologic evaluation, echocardio-
graphy, and genetic assays were all normal, so PHHI was 
suspected, and the patient was scheduled for pancreatectomy.
In the operating room, the patient underwent induction of 
anesthesia with sevoflurane and rocuronium (0.6 mg/kg) and 
was intubated with an uncuffed tube (internal diameter 3.0 mm). 
Anesthesia was maintained with oxygen and air (50 : 50 
mixture), sevoflurane (0.7-1.0 MAC), and intermittent doses 
of rocuronium. The left radial artery was cannulated with a 
24 G angio-catheter, and other monitoring included electro-
cardiogram, pulse oximetry, capnography, and esophageal 
temperature.
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Fig. 1. Blood glucose levels measured every 30 minutes during 
the operation. The arrow shows the moment that the specimen is 
removed.
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After induction, a BroviacⓇ catheter was inserted in the right 
internal jugular vein by the surgeon, and the operation was 
started. During the operation, 50 ml/hr of 10% dextrose solution 
was infused to prevent hypoglycemia, normal saline at a rate 
of 4 ml/kg/hr was used as maintenance fluid, and Hartmann's 
solution at a rate of 10 ml/kg/hr was used as replacement fluid. 
Estimated blood loss was 80 ml, so 50 ml of packed red blood 
cells was transfused. The patient's blood glucose was analyzed 
every 30 min, with a target blood glucose level of 80-180 mg/dl 
(Fig. 1). Immediately after removal of 95% of the pancreas, the 
10% dextrose solution infusion was stopped. 
At the end of the surgery we performed a blood gas analysis, 
also measuring blood glucose, which was 57 mg/dl. Therefore, 
we slowly injected 20 ml of 10% dextrose solution. The patient 
was extubated in the operating room when he was fully awake 
and breathing well. Emergence from anesthesia took about 
40 min, the total operation time was 5 hr 30 min, and the time 
under anesthesia was 7 hr 10 min.
Following extubation, the patient was transferred to the ICU. 
He was initially hyperglycemic, but this resolved spontaneously 
without any medication or intervention. After 1 day the patient’s 
condition had stabilized, and he was transferred to the general 
ward.
The patient recovered fully, without complications, and was 
discharged on the 25th day post operation. His glucose level 
was well controlled (95-268 mg/dl) without medication for 
glucose control, and a follow-up EEG after 1 month was normal. 
The patient is now healthy, growing and feeding well.
PHHI patients need glucose infusion rates greater than 8 to 
10 mg/kg/min to maintain plasma glucose above 45 mg/dl after 
the first day of life, but radiologic studies provide no diagnostic 
explanation for this elevated requirement, such as a pancreatic 
tumor. When the diagnosis is established, diazoxide is generally 
administered for a few days to suppress insulin production.
Our goal during the operation and anesthesia was to main-
tain normoglycemia to mild hyperglycemia throughout the 
dynamic intraoperative period and the fluid shifts of major 
surgery.
First of all, we had to consider the effect of the type of 
anesthetic management or agent used. There was a report that 
the use of a combination of general anesthesia and epidural 
anesthesia reduced the glucose requirement during surgery, 
because that method can suppress the stress response to 
major surgery in infants [2]. However, we elected to perform 
only general anesthesia with sevoflurane because of technical 
difficulties and the possibility of massive bleeding. Additionally, 
most inhaled anesthetics, with the exception of desflurane, 
depress insulin release [3] and promote glucose intolerance 
[4]. We therefore considered that performing only general 
anesthesia with sevoflurane would not significantly affect the 
blood glucose level of the infant in this study during anesthesia. 
Our second concern was to avoid hypoglycemia during 
the operation; we therefore used both continuous infusion 
and bolus injections of 10% dextrose when the blood glucose 
level dropped below 60 mg/dl, to maintain normoglycemia to 
moderate hyperglycemia. An additional consideration is that 
neonates and young children are susceptible to hypoglycemia 
due to immature ability of enzymatic glucose production and 
increased glucose requirements comparatively [5]. 
Finally, rebound hyperglycemia can occur after pancreatic 
mass excision, but it is transient, and in most cases resolves 
spontaneously after a few days, without intervention. In this 
case, a solution of 10% dextrose 4 ml/kg/hr was infused to 
provide glucose until pancreatic mass removal, at which time 
the infusion was stopped. Hyperglycemic rebound following 
complete near-total pancreatectomy began 1 hour after the 
resection. Immediately following the operation, hypoglycemia 
appeared, and a 10% dextrose bolus injection was given to the 
patient. Within a few days after the surgery, the patient’s glucose 
levels were well controlled without specific treatments.
In summary, pancreatecomy is semi-emergency surgery 
that is performed to protect the brain. It is a safe procedure 
that is well tolerated in infants and children, and successful 
anesthetic management depends on fluid management, to 
maintain normoglycemia in spite of changing glucose levels, 
and to maintain hemodynamic stability during the peri-
operative period. This procedure is always a challenge to many 
anesthesiologists.
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